343 related articles for article (PubMed ID: 38571961)
41. Organoid models in gynaecological oncology research.
Semertzidou A; Brosens JJ; McNeish I; Kyrgiou M
Cancer Treat Rev; 2020 Nov; 90():102103. PubMed ID: 32932156
[TBL] [Abstract][Full Text] [Related]
42. Liver organoid culture methods.
Hu Y; Hu X; Luo J; Huang J; Sun Y; Li H; Qiao Y; Wu H; Li J; Zhou L; Zheng S
Cell Biosci; 2023 Nov; 13(1):197. PubMed ID: 37915043
[TBL] [Abstract][Full Text] [Related]
43. Advance in Human Epithelial-Derived Organoids Research.
Li F; Zhang P; Wu S; Yuan L; Liu Z
Mol Pharm; 2021 Nov; 18(11):3931-3950. PubMed ID: 34582198
[TBL] [Abstract][Full Text] [Related]
44. The application of pancreatic cancer organoids for novel drug discovery.
Melzer MK; Resheq Y; Navaee F; Kleger A
Expert Opin Drug Discov; 2023 Apr; 18(4):429-444. PubMed ID: 36945198
[TBL] [Abstract][Full Text] [Related]
45. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.
Liu J; Li P; Wang L; Li M; Ge Z; Noordam L; Lieshout R; Verstegen MMA; Ma B; Su J; Yang Q; Zhang R; Zhou G; Carrascosa LC; Sprengers D; IJzermans JNM; Smits R; Kwekkeboom J; van der Laan LJW; Peppelenbosch MP; Pan Q; Cao W
Cell Mol Gastroenterol Hepatol; 2021; 11(2):407-431. PubMed ID: 32932015
[TBL] [Abstract][Full Text] [Related]
46. Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-β.
Goulart E; de Caires-Junior LC; Telles-Silva KA; Araujo BHS; Kobayashi GS; Musso CM; Assoni AF; Oliveira D; Caldini E; Gerstenhaber JA; Raia S; Lelkes PI; Zatz M
Stem Cell Res Ther; 2019 Aug; 10(1):258. PubMed ID: 31416480
[TBL] [Abstract][Full Text] [Related]
47. Advances in Microfluidic Technologies in Organoid Research.
Liu H; Gan Z; Qin X; Wang Y; Qin J
Adv Healthc Mater; 2023 Dec; ():e2302686. PubMed ID: 38134345
[TBL] [Abstract][Full Text] [Related]
48. Patient-Derived Organoids of Cholangiocarcinoma.
Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
[TBL] [Abstract][Full Text] [Related]
49. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
50. Cryopreservation of organoids.
Rogulska O; Havelkova J; Petrenko Y
Cryo Letters; 2023; 44(2):65-75. PubMed ID: 37883156
[TBL] [Abstract][Full Text] [Related]
51. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
52. Towards manufacturing of human organoids.
Ashok A; Choudhury D; Fang Y; Hunziker W
Biotechnol Adv; 2020; 39():107460. PubMed ID: 31626951
[TBL] [Abstract][Full Text] [Related]
53. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.
Gong M; Meng H; Tan D; Li P; Qin J; An Q; Shi C; An J
Animal Model Exp Med; 2023 Oct; 6(5):409-418. PubMed ID: 37890865
[TBL] [Abstract][Full Text] [Related]
54. Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.
Nuciforo S; Fofana I; Matter MS; Blumer T; Calabrese D; Boldanova T; Piscuoglio S; Wieland S; Ringnalda F; Schwank G; Terracciano LM; Ng CKY; Heim MH
Cell Rep; 2018 Jul; 24(5):1363-1376. PubMed ID: 30067989
[TBL] [Abstract][Full Text] [Related]
55. Urological cancer organoids, patients' avatars for precision medicine: past, present and future.
Chen H; Zhang W; Maskey N; Yang F; Zheng Z; Li C; Wang R; Wu P; Mao S; Zhang J; Yan Y; Li W; Yao X
Cell Biosci; 2022 Aug; 12(1):132. PubMed ID: 35986387
[TBL] [Abstract][Full Text] [Related]
56. Organoid technology for personalized pancreatic cancer therapy.
Bengtsson A; Andersson R; Rahm J; Ganganna K; Andersson B; Ansari D
Cell Oncol (Dordr); 2021 Apr; 44(2):251-260. PubMed ID: 33492660
[TBL] [Abstract][Full Text] [Related]
57. Xenograft and organoid model systems in cancer research.
Bleijs M; van de Wetering M; Clevers H; Drost J
EMBO J; 2019 Aug; 38(15):e101654. PubMed ID: 31282586
[TBL] [Abstract][Full Text] [Related]
58. Biomaterial-guided stem cell organoid engineering for modeling development and diseases.
Hoang P; Ma Z
Acta Biomater; 2021 Sep; 132():23-36. PubMed ID: 33486104
[TBL] [Abstract][Full Text] [Related]
59. From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer.
Betge J; Jackstadt R
Int J Cancer; 2023 Apr; 152(7):1304-1313. PubMed ID: 36121667
[TBL] [Abstract][Full Text] [Related]
60. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
